Omega 3 Fatty Acids: A Happy Mind and A Happy Body
Why are Omega-3 Fatty Acids important?
The American diet is not only lacking in essential Omega-3’s but is also heavy in saturated and trans fat. Omega-3’s are fatty acids with a special bond at their 3rd carbon. Due to their structure, they increase the fluidity of each cell’s outer membrane and thus allow each cell to function optimally. There is plentiful evidence that Omega-3’s decrease your risk of heart disease, high blood pressure, cancer, arthritis, allergies, diabetes, psychosis, eye disease and much more. Omega-3’s came into fashion for their cardiovascular effects, yet studies in the last decade affirm their benefit to the central nervous system. In fact, Omega-3’s are now supplemented in infant formulas to aid in brain development. Over the years I have observed an increasing number of respected neurologists and primary care doctors prescribe omega 3 fish oil as a first line treatment for concussion, memory problems, attention deficit disorder, bipolar mood disorder, depression, and behavior issues.
There are three omega 3 Fatty Acids:
–Alpha linoleic acid (ALA) is the most abundant but least effective. It is most commonly found in plants such as canola and flax seed.
–Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) are readily used by the body (unlike ALA), are found in seafood and not commonly in the American diet. EPA and DHA are often given in supplements. To avoid mercury toxicity, labels on these supplements should read: molecularly distilled, mercury and heavy metals have been eliminated, or US Pharmacopeial Convention (USP) grade. Most children tolerate Barlean’s Omega Swirl well and I often recommend this brand since there are many flavors to choose from.
How to introduce Omega-3 fatty acids into a child’s diet without supplementation:
Try baking rich Omega-3 fatty acid fish in teriyaki, barbecue or flavors your kids like with other proteins. Use this link from seafoodhealthfacts.org to reference the amount of Omega-3 fatty acids in each serving of fish that you cook. If your kids aren’t into fish try adding a teaspoon of flaxseed oil to a smoothie or practically anything with almond or peanut butter. You can also add ground flaxseeds to muffins, lasagna, casseroles, soups and even breadcrumbs before baking chicken.
The current Recommended Adequate Intake of Omega-3s for kids are:
- 0 to 12 months: 0.5 grams/day
- 1 to 3 years: 0.7 grams/day
- 4 to 8 years: 0.9 grams/day
- 9 to 13 years (boys): 1.2 grams/day
- 9 to 13 years (girls): 1.0 grams/day
- 14 to 18 years (boys): 1.6 grams/day
- 14 to 18 years (girls): 1.1 grams/day
As a dosing example, my son who is 2 years old needs 0.7 grams per day of DHA and EPA. I use Barlean’s Key Lime Omega Swirl which has 1.5 grams of DHA/EPA per 15 ml (1 tablespoon). I, therefore, give him approximately 7.5 ml (a little under 2 teaspoons). Remember that 720 mg = 0.7 g which is the serving for most of the Barlean’s flavors. On the other hand, when I give him salmon I give him 3 ounces to meet this daily amount.
To meet the daily needs of Omega-3 fats for kids, try these food sources:
- Fresh tuna
- Chia seeds
- Soy beans
Eggs, milk, and yogurt are commonly fortified with omega-3 fats and can be used as well.
*NIH Office of Dietary Supplements: “Omega-3 Fatty Acids and Health” and UpToDate: “Fish oil and marine omega-3 fatty acids”
- Age-Related Eye Disease Study 2 (AREDS2) research group.Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration. The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005–2015.
- Anandan C, Nurmatov U, Sheikh A.Omega 3 and 6 oils for primary prevention of allergic disease: systematic review and meta-analysis. 2009;64(6):840–848.
- Appleton KM, Rogers PJ, Ness AR.Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. American Journal of Clinical Nutrition. 2010;91(3):757–770.
- Bent S, Bertoglio K, Hendren RL.Omega-3 fatty acids for autistic spectrum disorder: a systematic review. Journal of Autism and Developmental Disorders. 2009;39(8):1145–1154.
- Black LI, Clarke TC, Barnes PM, Stussman BJ, Nahin RL.Use of complementary health approaches among children aged 4‒17 years in the United States: National Health Interview Survey, 2007‒2012. National health statistics reports; no 78. Hyattsville, MD: National Center for Health Statistics. 2015.
- Brasky TM, Till C, White E, et al.Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. American Journal of Epidemiology. 2011;173(12):1429–1439.
- Buckley JD, Howe PR.Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obesity Reviews. 2009;10(6):648–659.
- Calder PC, Yaqoob P.Omega-3 polyunsaturated fatty acids and human health outcomes. 2009;35(3):266–272.
- Chew EY, Clemons TE, Agrón E, et al.Effect of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient supplementation on cognitive function. The AREDS2 randomized clinical trial. JAMA. 2015;314(8):791-801.
- Chong EW-T, Kreis AJ, Wong TY, et al.Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration. A systematic review and meta-analysis. Archives of Ophthalmology. 2008;126(6):826–833.
- Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL.Trends in the use of complementary health approaches among adults: United States, 2002–2012 [240K <a href=”#pdf”>PDF</a>]. National health statistics reports; no 79. Hyattsville, MD: National Center for Health Statistics. 2015.
- Covington MB.Omega-3 fatty acids. American Family Physician. 2004;70(1):133–140.
- De Ley M, de Vos R, Hommes DW, et al.Fish oil for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews. 2007;(4):CD005986 [edited 2008]. Accessed at thecochranelibrary.com(link is external) on November 2, 2012.
- Farinotti M, Simi S, Di Pietrantonj C, et al. Dietary interventions for multiple sclerosis.Cochrane Database of Systematic Reviews. 2007;(1):CD004192 [edited 2009]. Accessed at thecochranelibrary.com(link is external) on November 2, 2012.
- Fassett RG, Gobe GC, Peake JM, et al.Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. American Journal of Kidney Diseases. 2010;56(4):728–742.
- Filion KB, El Khoury F, Bielinski M, et al.Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials.BMC Cardiovascular Disorders. 2010;10:24.
- Grey A, Bolland M.Clinical trial evidence and use of fish oil supplements. JAMA Internal Medicine. 2014;174(3):460-462.
- Hooper L, Harrison RA, Summerbell CD, et al.Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database of Systematic Reviews. 2004;(4):CD003177 [edited 2009]. Accessed at thecochranelibrary.com(link is external) on November 2, 2012.
- Hu FB, Manson JE.Omega-3 fatty acids and secondary prevention of cardiovascular disease—is it just a fish tale? Archives of Internal Medicine. 2012;172(9):694–696.
- Huang TL.Omega-3 fatty acids, cognitive decline, and Alzheimer’s disease: a critical review and evaluation of the literature. Journal of Alzheimer’s Disease. 2010;21(3):673–690.
- Irving CB, Mumby-Croft R, Joy LA.Polyunsaturated fatty acid supplementation for schizophrenia. Cochrane Database of Systematic Reviews. 2006;(3):CD001257 [edited 2010]. Accessed at thecochranelibrary.com(link is external) on November 2, 2012.
- Kris-Etherton PM, Harris WS, Appel LJ, et al.Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. 2002;106(21):2747–2757.
- Kwak SM, Myung S-K, Lee YJ, et al.Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease. A meta-analysis of randomized, double-blind, placebo-controlled trials. Archives of Internal Medicine. 2012;172(9):686–694.
- Lee JH, O’Keefe JH, Lavie CJ, et al.Omega-3 fatty acids: cardiovascular benefits, sources and sustainability. Nature Reviews. Cardiology. 2009;6(12):753–758.
- Miles EA, Calder PC.Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. British Journal of Nutrition.2012;107(Suppl 2):S171–S184.
- Oh R.Practical applications of fish oil (omega-3 fatty acids) in primary care.Journal of the American Board of Family Practice. 2005;18(1):28–36.
- Oliver C, Everard M, N’Diaye T. Omega-3 fatty acids (from fish oils) for cystic fibrosis.Cochrane Database of Systematic Reviews. 2007;(4):CD002201 [edited 2010]. Accessed at thecochranelibrary.com(link is external) on November 2, 2012.
- Raz R, Gabis L.Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. Developmental Medicine and Child Neurology. 2009;51(8):580–592.
- Riediger ND, Othman RA, Suh M, et al.A systemic review of the roles of n-3 fatty acids in health and disease. Journal of the American Dietetic Association. 2009;109(4):668–679.
- Rizos EC, Ntzani EE, Bika E, et al.Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events. A systematic review and meta-analysis. 2012;308(10):1024–1033.
- Salari P, Rezaie A, Larijani B, et al.A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Medical Science Monitor. 2008;14(3):RA37–44.
- Saravanan P, Davidson NC, Schmidt EB, et al.Cardiovascular effects of marine omega-3 fatty acids. Lancet. 2010;376 (9740):540–550.
- Szymanski KM, Wheeler DC, Mucci LA.Fish consumption and prostate cancer risk: a review and meta-analysis. American Journal of Clinical Nutrition. 2010;92(5):1223–1233.
- Turner D, Zlotkin SH, Shah PS, et al.Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn’s disease. Cochrane Database of Systematic Reviews. 2009;(1):CD006320. Accessed at thecochranelibrary.com(link is external) on November 2, 2012.
- Weitz D, Weintraub H, Fisher E, et al.Fish oil for the treatment of cardiovascular disease. Cardiology in Review. 2010;18(5):258–263.